Glucosidase inhibitory activity and antioxidant activity of flavonoid compound and triterpenoid compound from Agrimonia Pilosa Ledeb

BMC Complementary and Alternative Medicine

Volumn 14, Issue , 2014, Pages

  Liu, Xi ^a   Zhu, Liancai ^a   Tan, Jun ^b   Zhou, Xuemei ^a   Xiao, Ling ^a   Yang, Xian ^c   Wang, Bochu ^a  

^a CHONGQING UNIVERSITY   (China)

^b CHONGQING UNIVERSITY OF EDUCATION   (China)

^c CHONGQING NORMAL UNIVERSITY   (China)

Author keywords

Flavonoid compound; Oxidative stress; Postprandial hyperglycemia; Triterpenoid compound; Type 2 diabetes mellitus

Indexed keywords

1BETA,2BETA,3BETA,19ALPHA TETRAHYDROXY 12 EN 28 OIC ACID; 4 NITROPHENYL ALPHA GLUCOPYRANOSIDE; AGRIMONIA PILOSA EXTRACT; ALCOHOL; ALPHA GLUCOSIDASE INHIBITOR; ANTIOXIDANT; APIGENIN; BETA CAROTENE; CHEMICAL COMPOUND; COROSOLIC ACID; FLAVONOID; FLAVONOID COMPOUND; GLUCOPYRANOSIDE; GLUCOSIDASE; HYPERIN; KAEMPFEROL; LINOLEIC ACID; LUTEOLIN; LUTEOLIN 7 GLUCOSIDE; OLEANOLIC ACID; PLANT MEDICINAL PRODUCT; QUERCETIN; QUERCITRIN; RUTOSIDE; SEPHADEX; SILICA GEL; TRITERPENOID; TRITERPENOID COMPOUND; UNCLASSIFIED DRUG; UNINDEXED DRUG; VITEXIN; 4-NITROPHENYL ALPHA-GLUCOSIDE; ALPHA GLUCOSIDASE; GLUCOSIDE; GLYCOSIDASE INHIBITOR; PLANT EXTRACT; SCAVENGER; TRITERPENE;

ABTS RADICAL SCAVENGING ASSAY; AGRIMONIA; AGRIMONIA PILOSA; ANTIOXIDANT ACTIVITY; ARTICLE; BLEACHING; CONTROLLED STUDY; DPPH RADICAL SCAVENGING ASSAY; EC50; ENZYME INHIBITION; ENZYME SUBSTRATE; EXTRACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROXYL RADICAL SCAVENGING ASSAY; HYPERGLYCEMIA; IC50; ISOLATION PROCEDURE; LIPID PEROXIDATION; LIQUID CHROMATOGRAPHY; NONHUMAN; OXIDATIVE STRESS; ULTRAVIOLET SPECTROPHOTOMETRY; ANALOGS AND DERIVATIVES; CHEMISTRY; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; ISOLATION AND PURIFICATION; KINETICS; METABOLISM; OXIDATION REDUCTION REACTION; POSTPRANDIAL STATE;

AGRIMONIA; ALPHA-GLUCOSIDASES; ANTIOXIDANTS; BETA CAROTENE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETES MELLITUS, TYPE 2; FLAVONOIDS; FREE RADICAL SCAVENGERS; GLUCOSIDES; GLYCOSIDE HYDROLASE INHIBITORS; HYPERGLYCEMIA; KINETICS; LIPID PEROXIDATION; OXIDATION-REDUCTION; OXIDATIVE STRESS; PLANT EXTRACTS; POSTPRANDIAL PERIOD; QUERCETIN; TRITERPENES;

EID: 84892415340     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-14-12     Document Type: Article

References (32)

1. Stumvoll M, Goldstein BJ, Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet 2005, 365:1333-1346. 10.1016/S0140-6736(05)61032-X, 15823385.
2. Labonte ED, Kirby RJ, Schildmeyer NM, Cannon AM, Huggins KW, Hui DY. Group 1B phospholipase A(2)-mediated lysophospholipid absorption directly contributes to postprandial hyperglycemia. Diabetes 2006, 55:935-941. 10.2337/diabetes.55.04.06.db05-1286, 2048981, 16567514.
3. Maritim AC, Sanders RA, Watkins JB. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxic 2003, 17:24-38.
4. Wright E, Scism-Bacon JL, Glass LC. Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia. Int J Clinic Pract 2006, 60:308-314.
5. Mooradian AD, Thurman JE. Drug therapy of postprandial hyperglycaemia. Drugs 1999, 57:19-29.
6. Bischoff H. Pharmacology of alpha-glucosidase inhibition. Eur J Clin Invest 1994, 24:3-10.
7. Johnston PS, Lebovitz HE, Coniff RE, Simonson DC, Raskin P, Munera CL. Advantages of a-Glucosidase Inhibition as monotherapy in elderly type 2 diabetic patients. J Clin Endocrin Metab 1998, 83:1515-1522.
8. Hanefeld M. The role of acarbose in the treatment of non-insulin-dependent diabetes mellitus. J Diabetes Complicat 1998, 12:228-237. 10.1016/S1056-8727(97)00123-2, 9647342.
9. Chakrabarti R, Rajagopalan R. Diabetes and insulin resistance associated disorders: disease and the therapy. Curr Sci 2002, 83:1533-1538.
10. Benalla W, Bellahcen S, Bnouham M. Antidiabetic medicinal plants as a source of alpha glucosidase inhibitors. Curr Diabetes Rev 2010, 6:247-254. 10.2174/157339910791658826, 20522017.
11. Rahimi R, Nikfar S, Larijani B, Abdollahi M. Review on the role of antioxidants in the management of diabetes and its complications. Biomed Pharmcother 2005, 59:365-373.
12. Johansen JS, Harris AK, Rychly DJ, Ergul A. Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice. Cardiovasc Diabetol 2005, 4:5-15. 10.1186/1475-2840-4-5, 1131912, 15862133.
13. Pharmacopoeia Commission of People's Republic of China Chinese Pharmacopoeia, Part I 2005, 67. Beijing: Chemical Industry Pres, Pharmacopoeia Commission of People's Republic of China.
14. Kato H, Li W, Koike M, Wang YH, Koike K. Phenolic glycosides from Agrimonia pilosa. Phytochemistry 2010, 71:1925-1929. 10.1016/j.phytochem.2010.08.007, 20810135.
15. Kouno I, Baba N, Ohni Y, Kawano N. Triterpenoids from Agrimonia pilosa. Phytochemistry 1998, 27:297-299.
16. Tundis R, Loizzo MR, Menichini F. Natural products as alpha-Amylase and alpha-glucosidase inhibitors and their hypoglycaemic potential in the treatment of diabetes: an update. Mini-Rev Med Chem 2010, 10:315-331.
17. Cazarolli LH, Zanatta L, Alberton EH, Figueiredo MSRB, Folador P, Damazio RG, Pizzolatti MG, Silva FRMB. Flavonoids: prospective drug candidates. Mini-Rev Med Chem 2008, 8:1429-1440.
18. Pharmacopoeia Commission of People's Republic of China Chinese Pharmacopoeia, Part I 2005, 239. Beijing: Chemical Industry Pres, Pharmacopoeia Commission of People's Republic of China.
19. Kang WY, Song YL, Zhang L. Alpha-Glucosidase inhibitory and antioxidant properties and antidiabetic activity of Hypericum ascyron L. Med Chem Res 2011, 20:809-816.
20. Blois MS. Antioxidant determinations by the use of a stable free radical. Nature 1958, 181:1199-1200.
21. De Avelar IGJ, Magalhaes MMM, Silva AB, Souza LL, Leitao AC, Hermes-Lima M. Reevaluating the role of 1,10-phenanthroline in oxidative reactions involving ferrous ions and DNA damage. BBA-Gen Subjects 2004, 1675:46-53.
22. Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-Evans C. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radical Bio Med 1999, 26:1231-1237.
23. Kabouche A, Kabouche Z, Ozturk M, Kolak U, Topcu G. Antioxidant abietane diterpenoids from Salvia barrelieri. Food Chem 2007, 102:1281-1287.
24. Miller HE. A simplified method for the evaluation of antioxidants. J Am Oil Chem Soc 1971, 48:91.
25. Subramanian R, Asmawi MZ, Sadikun A. In vitro alpha-glucosidase and alpha-amylase enzyme inhibitory effects of Andrographis paniculata extract and andrographolide. Acta Biochim Pol 2008, 55:391-398.
26. Prashanth D, Amit A, Samiulla DS, Asha MK, Padmaja R. α-Glucosidase inhibitory activity of Mangifera indica bark. Fitoterapia 2001, 72:686-688. 10.1016/S0367-326X(01)00293-3, 11543970.
27. Andrade-Cetto A, Becerra-Jimenez J, Cardenas-Vazquez R. α-glucosidase inhibiting activity of some Mexican plants used in the treatment of type 2 diabetes. J Ethnopharmacol 2008, 116:27-32. 10.1016/j.jep.2007.10.031, 18082348.
28. Uebanso T, Arai H, Taketani Y, Fukaya M, Yamamoto H, Mizuno A, Uryu K, Hada T, Takeda E. Extracts of Momordica charantia suppress postprandial hyperglycemia in rats. J Nutr Sci Vitaminol 2007, 53:482-488. 10.3177/jnsv.53.482, 18202535.
29. Hou WL, Li YF, Zhang Q, Wei X, Peng AH, Chen LJ, Wei YQ. Triterpene acids isolated from Lagerstroemia speciosa leaves as alpha-glucosidase inhibitors. Phytother Res 2009, 23:614-618. 10.1002/ptr.2661, 19107840.
30. Mendes APS, Borges RS, Neto AMJC, De Macedo LGM, Da Silva ABF. The basic antioxidant structure for flavonoid derivatives. J Mol Model 2012, 18(9):4073-4080. 10.1007/s00894-012-1397-0, 22527272.
31. Moskovitz J, Yim MB, Chock PB. Free radicals and disease Arch. Biochem Biophys 2002, 397:354-359.
32. Halliwell B. Antioxidants and human disease: a general introduction. Nutr Rev 1997, 55:S44-S52.